Some case reports have shown that patients with SCLC BM experienced a complete disappearance of recurrent BM and sustained complete remission after receiving a combination of multi-kinase inhibitors and PD-1/PD-L1 inhibitors (106). This evidence concerns the gene PDCD1 and small cell lung carcinoma.